Edition:
United Kingdom

Verona Pharma PLC (VRNA.OQ)

VRNA.OQ on NASDAQ Stock Exchange Global Market

12.52USD
11 Jan 2018
Change (% chg)

-- (--)
Prev Close
$12.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,955
52-wk High
$17.50
52-wk Low
$10.44

Select another date:

Thu, Sep 7 2017

BRIEF-Verona Pharma announces positive top-line data from Phase 2A clinical trial in COPD with RPL554 dosed in addition to Tiotropium

* ANNOUNCES POSITIVE TOP-LINE DATA FROM PHASE 2A CLINICAL TRIAL IN COPD WITH RPL554 DOSED IN ADDITION TO TIOTROPIUM (SPIRIVA) Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Select another date: